Patrys Limited
🏢 View company profile →10Patents
7Active
10Granted
41Portfolio score
Filing activity: Jul 2, 2003 → Mar 14, 2014 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8124080B2 | Human monoclonal antibody having fat-reducing effect | Chemistry; Metallurgy | 1 | Active |
| US9273125B2 | Human monoclonal antibody having fat-reducing effect | Chemistry; Metallurgy | 1 | Active |
| US8562995B2 | Neoplasm specific antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8741296B2 | Adenocarcinoma specific antibody SAM-6, and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US7947812B2 | Neoplasm specific antibodies and uses thereof | Chemistry; Metallurgy | 1 | Expired |
| US7772372B2 | Neoplasm specific antibodies and uses thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7741444B2 | Neoplasm specific antibodies and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9265817B2 | PAT-LM1 epitopes and methods for using same | Chemistry; Metallurgy | 0 | Active |
| US8163552B2 | Adenocarcinoma specific antibody SAM-6, and uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US9783599B2 | LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.